Axsome Therapeutics (AXSM) Return on Sales: 2023-2025
Historic Return on Sales for Axsome Therapeutics (AXSM) over the last 3 years, with Sep 2025 value amounting to -0.41%.
- Axsome Therapeutics' Return on Sales rose 51.00% to -0.41% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.41%, marking a year-over-year increase of 51.00%. This contributed to the annual value of -0.74% for FY2024, which is 14.00% up from last year.
- As of Q3 2025, Axsome Therapeutics' Return on Sales stood at -0.41%, which was up 18.01% from -0.50% recorded in Q2 2025.
- In the past 5 years, Axsome Therapeutics' Return on Sales registered a high of -0.41% during Q3 2025, and its lowest value of -1.18% during Q1 2024.
- Over the past 3 years, Axsome Therapeutics' median Return on Sales value was -0.89% (recorded in 2023), while the average stood at -0.83%.
- Per our database at Business Quant, Axsome Therapeutics' Return on Sales decreased by 5bps in 2024 and then soared by 56bps in 2025.
- Axsome Therapeutics' Return on Sales (Quarterly) stood at -0.88% in 2023, then grew by 14bps to -0.74% in 2024, then surged by 51bps to -0.41% in 2025.
- Its Return on Sales was -0.41% in Q3 2025, compared to -0.50% in Q2 2025 and -0.64% in Q1 2025.